David Geffen School of Medicine at UCLA NICHD CRS — Los Angeles, California

David Geffen School of Medicine at UCLA NICHD CRS is a clinical research site located in Los Angeles, California, United States 90095-1752.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

David Geffen School of Medicine at UCLA NICHD CRS has participated in 14 clinical trials.

Therapeutic areas: HIV Infections, Respiratory Syncytial Virus Infections, HIV.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for David Geffen School of Medicine at UCLA NICHD CRS?

David Geffen School of Medicine at UCLA NICHD CRS has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has David Geffen School of Medicine at UCLA NICHD CRS conducted?

David Geffen School of Medicine at UCLA NICHD CRS has 14 clinical trials on record. Their work covers HIV Infections, Respiratory Syncytial Virus Infections, HIV.

Is David Geffen School of Medicine at UCLA NICHD CRS accredited by Crixeo Clinical Trials?

David Geffen School of Medicine at UCLA NICHD CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about David Geffen School of Medicine at UCLA NICHD CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.